DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 02 · Volume 53 · 1985 DOI: 10.1055/s-008-40682

Original Article

  • 165
    Laug, Walter E:

    Vascular Smooth Muscle Cells Inhibit the Plasminogen Activators Secreted by Endothelial Cells

  • 170
    Schleef, Raymond R; Sinha, Manjula; Loskutoff, David J:

    Characterization of Two Monoclonal Antibodies Against Human Tissue-Type Plasminogen Activator

  • 176
    Steiner, M:

    Dynamics of Platelet Tubulin in Response to Changes in Free Sulfhydryl Groups

  • 180
    Chorba, T L; Jason, J M; Ramsey, R B; Lechner, K; Pabinger-Fasching, I; Kalyanaraman, V S; McDougal, J S; Cabradilla, C D; Tregillus, L C; Lawrence, D N; Evatt, B L:

    HTLV-I Antibody Status in Hemophilia Patients Treated with Factor Concentrates Prepared from U.S. Plasma Sources and in Hemophilia Patients with AIDS

  • 183
    Harfenist, Elizabeth J; Packham, Marian A; Mustard, J Fraser:

    Comparison of the Interactions of Fibrinogen and Soluble Fibrin with Washed Rabbit Platelets Stimulated with ADP

  • 188
    Jung, Stephanie M; Tanoue, Kenjiro; Yamazaki, Hiroh:

    The Electrophoretic Mobility Heterogeneity of Human Platelet Subpopulations of Different Buoyant Densities

  • 195
    Berrettini, Mauro; Parise, Pasquale; Costantini, Vincenzo; Grasselli, Serena; Nenci, Giuseppe G:

    Platelet Activation in Psoriasis

  • 198
    Meade, T W; Stirling, Y; Wikes, H; Mannucci, P M:

    Effects of Oral Contraceptives and Obesity on Protein C Antigen

  • 200
    Electricwala, A; Ling, R J; Sutton, P M; Griffiths, B; Riley, P A; Atkinson, T:

    In Vitro Studies on the Fibrinolytic, Thrombolytic and Fibrinogenolytic Properties of a Tissue Plasminogen Activator from Guinea Pig Keratocytes

  • 204
    Takahashi, Hoyu; Shibata, Akira:

    Agglutination of Platelet-Type von Willebrand’s Disease Platelets by Bovine von Willebrand Factor

  • 208
    Bratt, G; Törnebohm, E; Lockner, D; Bergströ, G:

    A Human Pharmacological Study Comparing Conventional Heparin and a Low Molecular Weight Heparin Fragment

  • 212
    Princen, H M G; Moshage, H J; Emeis, J J; de Haard, H J W; Nieuwenhuizen, W; Yap, S H:

    Fibrinogen Fragments X, Y, D and E Increase Levels of Plasma Fibrinogen and Liver mRNAs Coding for Fibrinogen Polypeptides in Rats

  • 216
    Thompson, S G; Vickers, M V:

    Methods in Dose Response Platelet Aggregometry

  • 219
    Vickers, M V; Thompson, S G:

    Sources of Variability in Dose Response Platelet Aggregometry

  • 221
    Cattaneo, Marco; Canciani, Maria Teresa; Mannucci, Pier Mannuccio:

    Human Platelet Aggregation and Release Reaction Induced by Platelet Activating Factor (PAF-Acether) – Effects of Acetylsalicylic Acid and External Ionized Calcium

  • 225
    Carter, A J; Hanley, S P:

    The Effect of Platelet Number and Haematocrit on Whole Blood Thromboxane Synthesis

  • 228
    Hatton, Mark W C; Moar, Sue L:

    A Role for Pericellular Proteoglycan in the Binding of Thrombin or Antithrombin III by the Blood Vessel Endothelium? – The Effects of Proteoglycan-Degrading Enzymes and Glycosaminoglycan-Binding Proteins on 125I-Thrombin Binding by the Rabbit Thoracic Aorta In Vitro

  • 235
    Douglas, Jessie T; Blamey, S L; Lowe, G D O; Carter, D C; Forbes, C D:

    Plasma Beta-Thromboglobulin, Fibrinopeptide A and Bβ15–42 Antigen in Relation to Postoperative DVT, Malignancy and Stanozolol Treatment

  • 239
    Bergqvist, David:

    Prevention of Postoperative Thromboembolism in Sweden – The Development of Practice During Five Years

  • 242
    Czendlik, C; Lämmle, B; Ducket, F:

    Cold Promoted Activation and Factor XII, Prekallikrein and C1-Inhibitor

  • 245
    Rogatti, W; Yokoigawa, K; Kobayashi, T:

    Urokinase Quality: Analysis of Different Preparations

  • 249
    Francis, Robert B; McGehee, William G:

    Defibrination During Warfarin Therapy in a Man with Protein C Deficiency

  • 252
    Nowak, G; Markwardt, F:

    Influence of Cyproheptadine on Endotoxin-Induced Disseminated Intravascular Coagulation (DIC) in Weaned Pigs

  • 255
    Gram, Jørgen; Jespersen, Jørgen:

    A Functional Plasminogen Assay Utilizing the Potentiating Effect of Fibrinogen to Correct for the Overestimation of Plasminogen in Pathological Plasma Samples

  • 260
    Boneu, A; Sié, P; Bugat, R; Caranobe, C; Eber, M; Cazenave, J P; Boneu, B:

    Platelet Regeneration Time After Aspirin Ingestion and Platelet Survival Time After Labelling with 51Chromium or 111Indium Oxine – A Comparative Study

  • 264
    Sicard, Béatrice; Lagarde, Michel:

    Incorporation of Some Eicosaenoic Acids into Endothelial Cells – Effect on Platelet Inhibitory Activity and Prostacyclin Production

  • 268
    Bertina, R M; van Wijngaarden, A; Reinalda-Poot, J; Poort, S R; Bom, V J J:

    Determination of Plasma Protein S - The Protein Cofactor of Activated Protein C

  • 273
    Broekmans, A W; Bertina, R M; Reinalda-Poot, J; Engesser, L; Muller, H P; Leeuw, J A; Michiels, J J; Brommer, E J P; Briët, E:

    Hereditary Protein S Deficiency and Venous Thrombo-Embolism

  • 278
    Holm, H Asbjørn; Abildgaard, Ulrich; Kalvenes, Sigmund:

    Heparin Assays and Bleeding Complications in Treatment of Deep Venous Thrombosis with Particular Reference to Retroperitoneal Bleeding

    • International Committee Communications

  • 282
    Kaplan, Karen L; Niewiarowski, Stefan:

    Nomenclature of Secreted Platelet Proteins – Report of the Working Party on Secreted Platelet Proteins of the Subcommittee on Platelets

    • Letter to the Editor

  • 285
    Sinzinger, H:

    The Effect of Dihydroergotamine on Various Platelet Function Tests and Venous Prostacyclin-Formation in Men

  • 287
    Griffiths, Dr. B L:

    Monitoring the Intrinsic Pathway of Coagulation During Heparin Therapy – Reply

  • 288
    Fabris, Fabrizio; Luzzatto, Guido; Girolami, Antonio:

    The Value of βTG/PF4 Ratio in Patients with High Platelet Count

  • 289
    Viero, Piera; Cortelazzo, Sergio; Barbui, Tiziano:

    The Value of βTG/PF4 Ratio in Patients with High Platelet Count – Reply